Nasdaq:US$16.36 (-0.09) | HKEX:HK$25.70 (-0.40) | AIM:£2.71 (+0.01)
News & Presentations
Previous Article   |   Next Article
Presentations | 6 Jun 2022

ASCO2022: Surufatinib in US Patients with Soft Tissue Sarcoma